Purine and Pyrimidine Metabolism

Por Smyth, J. F.
Publicado em 1977

Progress in Clinical and Biological Research

Por Smyth, J. F.
Publicado em 1979

Purchasing Research from or for the NHS?

Por Smyth, J F
Publicado no J R Coll Physicians Lond (1994)

Small intestinal mucosal toxicity of cis-platinum--comparison of toxicity with platinum analogues and dexamethasone.

Por Allan, S. G., Smyth, J. F.
Publicado em 1986

Studying lung cancer in the laboratory--2: Chemosensitivity testing.

Por Fergusson, R J, Smyth, J F
Publicado em 1987

Studying lung cancer in the laboratory: 1--Development of model systems.

Por Fergusson, R J, Smyth, J F
Publicado em 1987

Studying lung cancer in the laboratory: 3--Use of cell lines to investigate the biology of lung cancer.

Por Fergusson, R J, Smyth, J F
Publicado em 1987

Adenosine deaminase activity in leukaemia.

Por Smyth, J. F., Harrap, K. R.
Publicado em 1975

Human tumour xenografts growing in immunodeficient mice: a useful model for assessing chemotherapeutic agents in bronchial carcinoma.

Por Fergusson, R J, Carmichael, J, Smyth, J F
Publicado em 1986

Role of adenosine deaminase in lymphocyte proliferation.

Por Hovi, T, Smyth, J F, Allison, A C, Williams, S C
Publicado em 1976

Induction of apoptosis in human cancer cell lines by the novel anthracenyl-amino acid topoisomerase I inhibitor NU/ICRF 505.

Por Meikle, I., Cummings, J., Macpherson, J. S., Smyth, J. F.
Publicado em 1996

Paraneoplastic hypercalcaemia in ovarian carcinoma.

Por Allan, S G, Lockhart, S P, Leonard, R C, Smyth, J F
Publicado em 1984

Action of deoxycoformycin on human T cell colonies in vitro.

Por Colledge, N R, Krajewski, A S, Smyth, J F, Wyllie, A H
Publicado em 1982

The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison.

Por Shorthouse, A. J., Peckham, M. J., Smyth, J. F., Steel, G. G.
Publicado em 1980

Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.

Por Fergusson, R. J., Anderson, L. E., Macpherson, J. S., Robins, P., Smyth, J. F.
Publicado em 1988

A prognostic model for ovarian cancer

Por Clark, T G, Stewart, M E, Altman, D G, Gabra, H, Smyth, J F
Publicado em 2001

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)

Por Sewell, J M, Macleod, K G, Ritchie, A, Smyth, J F, Langdon, S P
Publicado em 2002

Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.

Por Smyth, J F, Poplack, D G, Holiman, B J, Leventhal, B G, Yarbro, G
Publicado em 1978

Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management.

Por Allan, S G, Rodger, A, Smyth, J F, Leonard, R C, Chetty, U, Forrest, A P
Publicado em 1985

Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.

Por Warrington, P S, Allan, S G, Cornbleet, M A, MacPherson, J S, Smyth, J F, Leonard, R C
Publicado em 1986